NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Patients in the compassionate use program have to pay for the drug. The Advent rate card is over $200,000 and nowhere is NWBO's revenue's reflect much volume:

2022 $1,683 (000)
2021 $1,005
2020 $1,291

This revenue would represent about a dozen patients paying for compassionate use treatment,
Math and clinical data don't support the Dr. Liau's or your statements.